Amanda Krause, MBBCH, PhD, University of the Witwatersrand, Johannesburg, South Africa, discusses the ethical concerns raised around Huntington’s phenocopy diagnosis due to the severity of the disease and lack of treatment. Prof. Krause expresses that consent of the individual is important and that no one is tested before undergoing predictive assessment and genetic counseling. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).